Global Pigmentation Disorders Treatment Market is expected to reach US$ 8.59 Bn. at a CAGR of 7.2 during the forecast period 2026.Global Pigmentation Disorders Treatment Market Overview:
Pigmentation disorders are skin tissue abnormalities that can be recognised, examined, and treated in primary care settings. When compared to the pre-existing skin colour, this disease can produce either skin lightening or skin darkening.Global Pigmentation Disorders Treatment Market Dynamics:
Increasing demand for skin lightening procedure is the major factor driving the market growth. Rising up-gradation of lifestyle along with an increase in demand for skin lightening is a major factor expected to drive the global pigmentation problem treatment market. Melanin, a skin component produced by some specific cells in the body, regulates skin colour. Pigmentation is caused by damaged or diseased melanin-producing cells that produce too little or too much melanin. Melasma (hyperpigmentary disorder), vitiligo (hypopigmentary disorder), albinism (inherited uncommon disorder), and post-inflammatory hyperpigmentation are the most frequent pigmentation diseases. Environmental changes, such as global warming, have a substantial impact on the skin and are expected to aid the industry's growth in the next years. Furthermore, advancements in tissue engineering, as well as a spike in fresh methods for boosting aesthetics and skincare products, will aid the industry in achieving maximum revenue in the near future. Other factors driving the global pigmentation problem treatment market include an ageing population, an increase in the frequency of skin problems, and rising disposable income. Growing consumer knowledge of cosmeceutical and cosmetics goods, such as anti-aging, sun care, and hair care, and beauty, is predicted to improve the industry's growth potential in the future. The introduction of natural and plant-based components has been critical in meeting the global demand for cosmeceutical products. The exorbitant expenses of cosmetic treatments and surgery, on the other hand, are limiting the market growth. The report has profiled nineteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Global Pigmentation Disorders Treatment Market Segment Analysis:
The Global Pigmentation Disorders Treatment Market is segmented on the basis of Type of Disorder, Treatment and Distribution Channel. Based on Type of Disorder, the Melasma segment is dominating the global market. Melasma is currently leading the illness type sector because of its high incidence rate in the Caucasian population, which accounts for 55% to 60% of the global population. Melasma affects 90% of women worldwide, and it is caused by hormonal fluctuations, pregnancy, and birth control drugs.To know about the Research Methodology :- Request Free Sample Report Based on Treatment, the Topical Treatment segment is expected to grow at a significant CAGR of XX% during the forecast period. Due to improved clinical outcomes in individuals with pigmentation disorders, topical therapy is currently dominating the global market. Azelaic acid, hydroquinone, L-ascorbic acid, and other topical medicines are the most commonly recommended worldwide. Due to the highest occurrence of melasma in the white population, topical therapy comprises hydroquinone as a first-line drug, as well as a retinoid. According to the National Clinical Trials (NCT) registry, Incyte Corporation is conducting a phase II clinical trial for Ruxolitinib in the treatment of Vitiligo in the United States as of June 18, 2020. If Ruxolitinib is approved for the treatment of Vitiligo in the near future, this aspect will raise the market.
Global Pigmentation Disorders Treatment Market Regional Insights:
North America is expected to hold the dominant market share during forecast period. Because of the increased prevalence of pigmentation disorders, North America dominates the global pigmentation disorders treatment market. In North America, there is a well-established healthcare infrastructure and large market companies that provide efficient treatment choices for patients with post-inflammatory hyperpigmentation. Due to increased beauty concern among Asians, rapid entry of new competitors into the market, and growth by major companies into emerging economies, the Asia Pacific region is witnessing a quick pace in the global pigmentation disorders treatment market. The report also helps in understanding Global Pigmentation Disorders Treatment Market dynamics, structure by analyzing the market segments and project the Global Pigmentation Disorders Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Pigmentation Disorders Treatment Market make the report investor’s guide.
Global Pigmentation Disorders Treatment Market Scope: Inquire before buying
Global Pigmentation Disorders Treatment Market, By Region:
• North America • Europe • South America • MEA • APACGlobal Pigmentation Disorders Treatment Market, Key players:
• Episciences, Inc. • La Roche-Posay • Bayer AG • Allergan, Inc. • SkinCeuticals International • Pierre Fabre Laboratories • Alvogen, Inc. • Obagi Medical Products Inc. • CLINUVEL PHARMACEUTICALS LTD • Clarify Medical, Inc • Incyte Corporation • Dr. Reddy’s Laboratories Ltd • Glenmark Pharmaceuticals Ltd • Teva Pharmaceutical Industries Ltd • Bausch Health • Novartis AG • Mylan N.V. • Pfizer Inc • Panacea Biotec Ltd
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Pigmentation Disorders Treatment Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Pigmentation Disorders Treatment Market 3.4. Geographical Snapshot of the Pigmentation Disorders Treatment Market, By Manufacturer share 4. Global Pigmentation Disorders Treatment Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Pigmentation Disorders Treatment Market 5. Supply Side and Demand Side Indicators 6. Global Pigmentation Disorders Treatment Market Analysis and Forecast, 2019-2026 6.1. Global Pigmentation Disorders Treatment Market Size & Y-o-Y Growth Analysis. 7. Global Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 7.1.1. Albinism 7.1.2. Melasma 7.1.3. Post-Inflammatory Hyperpigmentation (PIH) 7.1.4. Other Type of Disorders 7.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 7.2.1. Topical Treatment 7.2.2. Dermabrasion 7.2.3. Chemical peels 7.2.4. Laser Treatment 7.2.5. Phototherapy 7.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 7.3.1. E-commerce 7.3.2. Dermatology Clinics 7.3.3. Drugstores and Cosmetic Stores 7.3.4. Others 8. Global Pigmentation Disorders Treatment Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 9.1.1. Albinism 9.1.2. Melasma 9.1.3. Post-Inflammatory Hyperpigmentation (PIH) 9.1.4. Other Type of Disorders 9.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 9.2.1. Topical Treatment 9.2.2. Dermabrasion 9.2.3. Chemical peels 9.2.4. Laser Treatment 9.2.5. Phototherapy 9.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 9.3.1. E-commerce 9.3.2. Dermatology Clinics 9.3.3. Drugstores and Cosmetic Stores 9.3.4. Others 10. North America Pigmentation Disorders Treatment Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 12. Canada Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 13. Mexico Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 14. Europe Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 15. Europe Pigmentation Disorders Treatment Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 17. France Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 18. Germany Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 19. Italy Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 20. Spain Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 21. Sweden Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 22. CIS Countries Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 23. Rest of Europe Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 24. Asia Pacific Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 25. Asia Pacific Pigmentation Disorders Treatment Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 27. India Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 28. Japan Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 29. South Korea Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 30. Australia Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 31. ASEAN Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 32. Rest of Asia Pacific Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 33. Middle East Africa Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 34. Middle East Africa Pigmentation Disorders Treatment Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 36. GCC Countries Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 37. Egypt Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 38. Nigeria Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 39. Rest of ME&A Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 40. South America Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 41. South America Pigmentation Disorders Treatment Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 43. Argentina Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 44. Rest of South America Pigmentation Disorders Treatment Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Type of Disorders, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Treatment, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Pigmentation Disorders Treatment Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Episciences, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. La Roche-Posay 45.3.3. Bayer AG 45.3.4. Allergan, Inc. 45.3.5. SkinCeuticals International 45.3.6. Pierre Fabre Laboratories 45.3.7. Alvogen, Inc. 45.3.8. Obagi Medical Products Inc. 45.3.9. CLINUVEL PHARMACEUTICALS LTD 45.3.10. Clarify Medical, Inc 45.3.11. Incyte Corporation 45.3.12. Dr. Reddy’s Laboratories Ltd 45.3.13. Glenmark Pharmaceuticals Ltd 45.3.14. Teva Pharmaceutical Industries Ltd 45.3.15. Bausch Health 45.3.16. Novartis AG 45.3.17. Mylan N.V. 45.3.18. Pfizer Inc 45.3.19. Panacea Biotec Ltd 46. Primary Key Insights